| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c36819c054f29562209fd22c3d23ff0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-528
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2010-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6693068ed3b62de6d1760fa440564e0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_397c5ff2b4bba2accec547bbf08ec03f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95344128dbb3ca96b8a71a3266f79898 |
| publicationDate |
2019-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2712997-T3 |
| titleOfInvention |
Selection as target of bone marrow neovasculature |
| abstract |
Antibody that binds to domain A1 of the large tenascin-C isoform for use in a method of treating acute myeloid leukemia (AML) that involves targeting bone marrow neovasculature in patients with AML. |
| priorityDate |
2009-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |